Up-regulation of drug resistance-related vaults during dendritic cell development

Journal of Immunology

Volumn 168, Issue 4, 2002, Pages 1572-1578

  Schroeijers, Anouk B ^a   Reurs, Anneke W ^a   Scheffer, George L ^a   Stam, Anita G M ^a   De Jong, Mariska C ^a   Rustemeyer, Thomas ^a   Wiemer, Erik A C ^a   De Gruijl, Tanja D ^a   Scheper, Rik J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD1 ANTIGEN; CD34 ANTIGEN; CD83 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN P; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; RIBONUCLEOPROTEIN; T6 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; CELL SURVIVAL; CELL VIABILITY; CHRONIC MYELOID LEUKEMIA; CYTOKINE RELEASE; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LEUKEMIA CELL; LYMPHOCYTE PROLIFERATION; MONOCYTE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 0037083639     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.4.1572     Document Type: Article

References (37)

1. Immunobiology of dendritic cells
2. P-glycoprotein: A mediator of multidrug resistance in tumour cells
3. A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels
4. Dendritic cells: Unique leukocyte populations which control the primary, immune response
5. Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia
6. Vaults. II. Ribonucleoprotein structures are highly conserved among higher and lower eukaryotes
7. Interaction of vault particles with estrogen receptor in the MCF-7 breast cancer cell
8. Evidence that vault ribonucleoprotein particles localize to the nuclear pore complex
9. Characterization of the sea urchin major vault protein: A possible role for vault ribonucleoprotein particles in nucleocytoplasmic transport
10. The major vault protein (MVP100) is contained in cholinergic nerve terminals of electric ray electric organ
11. Recombinant major vault protein is targeted to neuritic tips of PC12 cells
12. Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells
13. Structure of the vault, a ubiquitous cellular component
14. Unlocking vaults: Organelles in search of a function
15. r 193,000 vault protein is up-regulated in multidrug-resistant cancer cell lines
16. r 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance
17. r 110,000 lung resistance-related protein lrp/mvp with monoclonal antibodies
18. Drug transport variants without P-glycoprotein overexpression from a human squamous lung cancer cell line after selection with doxorubicin
19. Multifactorial drug resistance in an Adriamycin-resistant human small cell lung carcinoma cell line
20. Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multi-drug-resistance
21. Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies
22. Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies
23. Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody
24. P-glycoprotein epitope mapping. I. Identification of a linear human-specific epitope in the fourth loop of the P-glycoprotein extracellular domain by MM4.17 murine monoclonal antibody to human multi-drug-resistant cells
25. Monoclonal antibody to an external epitope of the human mdr1 P-glycoprotein
26. A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM vaccines and conventional vaccines
27. Human cultured dendritic cells show differential sensitivity to chemotherapy agents as assessed by the MTS assay
28. Differential expression of the efflux pumps P-glycoprotein and multidrug resistance-associated protein in human monocyte-derived dendritic cells
29. Intracellular expression of P-170 glycoprotein in peripheral blood mononuclear cell subsets from healthy donors and HIV-infected patients
30. P-glycoprotein expression in the GoIgi apparatus of multidrug-resistant cells
31. Intrinsic expression of the multidrug transporter, P-glycoprotein 170, in multiple myeloma: Implications for treatment
32. Evidence that natural killer cells express mini P-glycoproteins but not classic 170 kDa P-glycoprotein
33. P-glycoprotein function involves conformational transitions detectable by differential immunoreactivity
34. 4 transporter MRP1 regulates CCL19 (MIP-3βELC)-dependent mobilization of dendritic cells to lymph nodes
35. Dictyostelium vaults: Disruption of the major proteins reveals growth and morphological defects and uncovers a new associated protein
36. Vaults are up-regulated in multidrug-resistant cancer cell lines
37. The drug resistance-related protein LRP is the human major vault protein